Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Watchlist Manager
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Watchlist
Price: 451.86 USD 0.33%
Market Cap: 116.4B USD
Have any thoughts about
Vertex Pharmaceuticals Inc?
Write Note

Income Statement

Earnings Waterfall
Vertex Pharmaceuticals Inc

Revenue
10.6B USD
Cost of Revenue
-1.5B USD
Gross Profit
9.2B USD
Operating Expenses
-4.9B USD
Operating Income
4.3B USD
Other Expenses
-4.8B USD
Net Income
-479.8m USD

Income Statement
Vertex Pharmaceuticals Inc

Rotate your device to view
Income Statement
Currency: USD
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
787
N/A
580
-26%
601
+3%
628
+5%
759
+21%
1 032
+36%
1 292
+25%
1 557
+21%
1 661
+7%
1 702
+2%
2 019
+19%
2 131
+6%
2 296
+8%
2 489
+8%
2 415
-3%
2 623
+9%
2 829
+8%
3 048
+8%
3 265
+7%
3 454
+6%
3 620
+5%
4 163
+15%
4 820
+16%
5 403
+12%
5 991
+11%
6 206
+4%
6 415
+3%
6 684
+4%
7 130
+7%
7 574
+6%
7 948
+5%
8 351
+5%
8 701
+4%
8 931
+3%
9 208
+3%
9 505
+3%
9 654
+2%
9 869
+2%
10 185
+3%
10 337
+1%
10 626
+3%
Gross Profit
Cost of Revenue
(69)
(40)
(58)
(57)
(75)
(117)
(163)
(191)
(213)
(207)
(207)
(233)
(252)
(273)
(300)
(333)
(371)
(410)
(433)
(464)
(485)
(548)
(615)
(664)
(718)
(736)
(766)
(810)
(860)
(904)
(958)
(992)
(1 044)
(1 080)
(1 101)
(1 148)
(1 178)
(1 262)
(1 338)
(1 401)
(1 475)
Gross Profit
718
N/A
541
-25%
543
+0%
571
+5%
684
+20%
915
+34%
1 129
+23%
1 366
+21%
1 448
+6%
1 495
+3%
1 812
+21%
1 899
+5%
2 044
+8%
2 216
+8%
2 115
-5%
2 290
+8%
2 458
+7%
2 638
+7%
2 832
+7%
2 990
+6%
3 135
+5%
3 615
+15%
4 204
+16%
4 739
+13%
5 273
+11%
5 469
+4%
5 649
+3%
5 874
+4%
6 270
+7%
6 670
+6%
6 990
+5%
7 359
+5%
7 656
+4%
7 850
+3%
8 107
+3%
8 357
+3%
8 477
+1%
8 607
+2%
8 847
+3%
8 936
+1%
9 151
+2%
Operating Income
Operating Expenses
(1 192)
(1 182)
(1 150)
(1 166)
(1 246)
(1 380)
(1 432)
(1 497)
(1 529)
(1 484)
(1 506)
(1 540)
(1 738)
(1 823)
(1 874)
(1 932)
(1 824)
(1 974)
(2 020)
(2 081)
(2 332)
(2 418)
(2 563)
(2 650)
(2 611)
(2 613)
(2 625)
(3 606)
(3 620)
(3 888)
(4 055)
(3 267)
(3 492)
(3 530)
(4 061)
(4 391)
(4 600)
(4 248)
(4 560)
(4 741)
(4 862)
Selling, General & Administrative
(300)
(305)
(317)
(334)
(359)
(377)
(396)
(413)
(420)
(433)
(441)
(457)
(471)
(496)
(513)
(523)
(539)
(558)
(575)
(594)
(616)
(659)
(694)
(729)
(754)
(771)
(780)
(783)
(797)
(840)
(863)
(884)
(933)
(945)
(971)
(1 018)
(1 035)
(1 137)
(1 238)
(1 348)
(1 456)
Research & Development
(893)
(856)
(833)
(832)
(887)
(996)
(1 036)
(1 083)
(1 110)
(1 048)
(1 066)
(1 084)
(1 267)
(1 325)
(1 362)
(1 410)
(1 285)
(1 417)
(1 445)
(1 487)
(1 712)
(1 755)
(1 864)
(1 905)
(1 843)
(1 830)
(1 837)
(2 823)
(2 824)
(3 051)
(3 198)
(2 440)
(2 620)
(2 643)
(3 129)
(3 377)
(3 564)
(3 163)
(3 372)
(3 442)
(3 456)
Other Operating Expenses
0
(21)
0
0
0
(7)
0
0
0
(4)
0
0
0
(2)
0
0
0
0
0
0
(3)
(5)
(6)
(15)
(14)
(13)
(8)
0
1
3
7
58
61
58
39
3
(1)
52
50
49
50
Operating Income
(475)
N/A
(642)
-35%
(607)
+5%
(595)
+2%
(562)
+6%
(465)
+17%
(303)
+35%
(130)
+57%
(81)
+38%
11
N/A
306
+2 629%
358
+17%
307
-14%
393
+28%
241
-39%
358
+49%
633
+77%
664
+5%
812
+22%
909
+12%
803
-12%
1 198
+49%
1 641
+37%
2 089
+27%
2 662
+27%
2 856
+7%
3 024
+6%
2 268
-25%
2 650
+17%
2 782
+5%
2 935
+5%
4 092
+39%
4 165
+2%
4 320
+4%
4 046
-6%
3 966
-2%
3 877
-2%
4 359
+12%
4 287
-2%
4 195
-2%
4 288
+2%
Pre-Tax Income
Interest Income Expense
(65)
(73)
(79)
(84)
(85)
(84)
(84)
(83)
(82)
(81)
(78)
(72)
(66)
(58)
(50)
(50)
(44)
(34)
(20)
(4)
(2)
10
(20)
54
119
100
88
9
(18)
(40)
(62)
(146)
(130)
(59)
147
378
480
563
630
621
598
Non-Reccuring Items
(74)
(14)
(41)
(44)
(5)
(2)
(6)
(4)
(3)
(1)
(11)
(14)
(269)
(270)
(260)
(256)
(0)
(29)
(29)
(29)
(29)
0
0
0
0
0
0
0
0
0
0
(13)
(13)
(13)
0
0
0
(527)
(95)
(4 544)
(4 559)
Total Other Income
38
(6)
25
(12)
(9)
(7)
3
0
1
4
(1)
(2)
(80)
(81)
15
75
91
(1)
(57)
(60)
(21)
187
111
87
125
160
168
135
116
(12)
(9)
(0)
4
(16)
(24)
(37)
(48)
(15)
(55)
(58)
(68)
Pre-Tax Income
(576)
N/A
(735)
-28%
(702)
+4%
(735)
-5%
(660)
+10%
(558)
+16%
(390)
+30%
(217)
+44%
(164)
+25%
(67)
+59%
217
N/A
270
+25%
(108)
N/A
(16)
+85%
(55)
-248%
126
N/A
680
+438%
600
-12%
706
+18%
816
+16%
751
-8%
1 395
+86%
1 732
+24%
2 230
+29%
2 905
+30%
3 117
+7%
3 280
+5%
2 411
-26%
2 748
+14%
2 730
-1%
2 864
+5%
3 933
+37%
4 027
+2%
4 232
+5%
4 169
-1%
4 306
+3%
4 309
+0%
4 380
+2%
4 767
+9%
215
-95%
260
+21%
Net Income
Tax Provision
(6)
(7)
(6)
(36)
(34)
(30)
(36)
(24)
(23)
(17)
(15)
(1)
125
107
124
118
(16)
(73)
(137)
(187)
(192)
(218)
(221)
(149)
(214)
(405)
(518)
(419)
(572)
(388)
(413)
(738)
(753)
(910)
(909)
(941)
(839)
(760)
(748)
(705)
(739)
Income from Continuing Operations
(582)
(742)
(708)
(770)
(694)
(588)
(426)
(241)
(187)
(84)
202
269
17
92
69
245
664
527
569
630
559
1 177
1 511
2 081
2 691
2 712
2 762
1 992
2 176
2 342
2 451
3 195
3 273
3 322
3 260
3 365
3 470
3 620
4 019
(490)
(480)
Income to Minority Interest
0
4
4
36
35
32
26
(34)
(32)
(28)
(24)
(9)
179
172
157
171
(17)
10
27
26
25
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
(518)
N/A
(739)
-43%
(705)
+5%
(734)
-4%
(659)
+10%
(556)
+16%
(399)
+28%
(275)
+31%
(219)
+20%
(112)
+49%
177
N/A
260
+46%
196
-25%
263
+35%
226
-14%
415
+84%
647
+56%
2 096
+224%
2 155
+3%
2 215
+3%
2 144
-3%
1 177
-45%
1 511
+28%
2 081
+38%
2 691
+29%
2 712
+1%
2 762
+2%
1 992
-28%
2 176
+9%
2 342
+8%
2 451
+5%
3 195
+30%
3 273
+2%
3 322
+1%
3 260
-2%
3 365
+3%
3 470
+3%
3 620
+4%
4 019
+11%
(490)
N/A
(480)
+2%
EPS (Diluted)
-2.19
N/A
-3.13
-43%
-2.94
+6%
-3.04
-3%
-2.74
+10%
-2.31
+16%
-1.64
+29%
-1.12
+32%
-0.89
+21%
-0.46
+48%
0.71
N/A
1.03
+45%
0.78
-24%
1.04
+33%
0.87
-16%
1.59
+83%
2.5
+57%
8.08
+223%
8.28
+2%
8.52
+3%
8.22
-4%
4.51
-45%
5.73
+27%
7.91
+38%
10.18
+29%
10.29
+1%
10.54
+2%
7.63
-28%
8.37
+10%
9.01
+8%
9.5
+5%
12.34
+30%
12.61
+2%
12.82
+2%
12.52
-2%
12.92
+3%
13.33
+3%
13.89
+4%
15.39
+11%
-1.89
N/A
-1.83
+3%

See Also

Discover More